RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
+7.18%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$216M
AUM Growth
+$216M
(-13%)
Cap. Flow
-$46.8M
Cap. Flow
% of AUM
-21.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$46.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $168M | 77.6% |
1,111,111
| – | – |
|
2
BioCryst Pharmaceuticals
BCRX
$1.74B
| $48.5M | 22.39% |
3,846,154
| – | – |
|
|
VIRX
3
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $16K | 0.01% |
3,700
| – | – |
|
|
EPZM
4
DELISTED
Epizyme, Inc
EPZM
| – | – |
-31,841,394
| Closed | -$46.8M |
|